Growth Disorders
62
4
8
40
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.8%
3 terminated out of 62 trials
93.0%
+6.5% vs benchmark
11%
7 trials in Phase 3/4
20%
8 of 40 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 40 completed trials
Clinical Trials (62)
PROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers in Children and Adolescents on Antipsychotics
NiPPeR Randomised Trial - Child Follow Up Study
The Efficacy and Safety of PEGylated GH for the Treatment of Short Stature in Chinese Children-GLOBE Reg
Growth Hormone in a Patient With a Dominant-Negative GHR Mutation
Impact of Screens on Children's Growth
Child Growth and Development in East London
The Effect of Interaction-Based Early Education Program Applied to Grandparents on the Grandchildren's Health
Is There a Microbiome Associated With Poor Growth in Preterm Infants?
Testing the Feasibility of a Novel Growth Monitoring Smartphone App
Evolutionary Nutrition Pilot: Enhancing Fetal Growth and Brain Development
Impact of Iron Deficiency Anemia on Neurobehavioral and Cognitive Development in Children Aged 6 to 24 Months
Identifying New Genetic Causes to Development Disorders
Use of Long Read Genome Sequencing in Patients Suffering From Neurodevelopmental Troubles
Evaluating the Effects of an Oral Protein Supplement on Children's Growth Patterns
Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children
CrescNet - Growth Monitoring Network
Growth Chart Parameters, Risk Factors
Long-Acting Growth Hormone in Children Compared to Daily rhGH
Growth Pattern and Characteristics of Cardiac Pediatric Patients
Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (Somavaratan, VRS-317)